Cellular components of the idiopathic epiretinal membrane

Imagem de Miniatura
Arquivos
art_SILVA_Cellular_components_of_the_idiopathic_epiretinal_membrane_2022.PDF (918.33 KB)
Citações na Scopus
16
Tipo de produção
article
Data de publicação
2022
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Autores
SILVA, Rafael Andre da
RODA, Vinicius Moraes de Paiva
SIQUEIRA, Paula Veloso
LUSTOZA-COSTA, Gabriela Jesus
WU, Davi Chen
HAMASSAKI, Dania Emi
Citação
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, v.260, n.5, p.1435-1444, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Idiopathic epiretinal membrane (iERM) is a fibrocellular proliferation on the inner surface of the retina, which leads to decreased visual acuity and even central visual loss. As iERM is associated to advanced age and posterior vitreous detachment, a higher prevalence is expected with increasing life expectancy and aging of the global population. Although various cell types of retinal and extra-retinal origin have been described in iERMs (Muller glial cells, astrocytes, hyalocytes, retinal pigment epithelium cells, myofibroblasts, and fibroblasts), myofibroblasts have a central role in collagen production and contractile activity. Thus, myofibroblast differentiation is considered a key event for the iERM formation and progression, and fibroblasts, Muller glial cells, hyalocytes, and retinal pigment epithelium have been identified as myofibroblast precursors. On the other side, the different cell types synthesize growth factors, cytokines, and extracellular matrix, which have a crucial role in ERM pathogenesis. In the present review, the major cellular components and their functions are summarized, and their possible roles in the iERM formation are discussed. By exploring in detail the cellular and molecular aspects of iERM, we seek to contribute for better understanding of this fibrotic disease and the origin of myofibroblasts, which may eventually drive to more targeted therapeutic approaches.
Palavras-chave
Epiretinal membrane, Hyalocyte, Muller cell, Myofibroblast, Retinal pigment epithelium cell, Transdifferentiation
URI
https://observatorio.fm.usp.br/handle/OPI/47473
Referências
  1. Akamine PS, 2021, EXP EYE RES, V204, DOI 10.1016/j.exer.2020.108434
  2. Baek J, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.2.19
  3. BALAZS EA, 1964, EXP EYE RES, V3, P57, DOI 10.1016/S0014-4835(64)80008-7
  4. Boneva SK, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.567274
  5. Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003
  6. Bringmann A, 2009, GRAEF ARCH CLIN EXP, V247, P865, DOI 10.1007/s00417-009-1082-x
  7. Bu SC, 2015, INVEST OPHTH VIS SCI, V56, P6506, DOI 10.1167/iovs.14-15971
  8. Bu SC, 2014, RETINA-J RET VIT DIS, V34, P2317, DOI 10.1097/IAE.0000000000000349
  9. Bu SC, 2014, RETINA-J RET VIT DIS, V34, P897, DOI 10.1097/IAE.0000000000000013
  10. Castanos MV, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.6.48
  11. Chen XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096365
  12. Chen ZN, 2015, MOL VIS, V21
  13. Cheung N, 2017, BRIT J OPHTHALMOL, V101, P371, DOI 10.1136/bjophthalmol-2016-308563
  14. Choi K, 2012, MOL VIS, V18, P1010
  15. Christakopoulos C, 2019, EXP EYE RES, V186, DOI 10.1016/j.exer.2019.107722
  16. Coltrini D, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165938
  17. Eastlake K, 2016, GLIA, V64, P495, DOI 10.1002/glia.22942
  18. Edwards MM, 2016, EXP EYE RES, V150, P44, DOI 10.1016/j.exer.2015.07.016
  19. Eme-Scolan E, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.583647
  20. Escartin C, 2021, NAT NEUROSCI, V24, P312, DOI 10.1038/s41593-020-00783-4
  21. Feist RM, 2014, GRAEF ARCH CLIN EXP, V252, P347, DOI 10.1007/s00417-013-2531-0
  22. FOOS RY, 1977, INVEST OPHTH VIS SCI, V16, P416
  23. FOOS RY, 1974, A GRAEF ARCH KLIN EX, V189, P231, DOI 10.1007/BF02384852
  24. Fung AT, 2021, CLIN EXP OPHTHALMOL, V49, P289, DOI 10.1111/ceo.13914
  25. GABBIANI G, 1972, J EXP MED, V135, P719, DOI 10.1084/jem.135.4.719
  26. Gass, 1997, STEREOSCOPIC ATLAS M, P938
  27. Guenther SR, 2019, CURR EYE RES, V44, P341, DOI 10.1080/02713683.2018.1542006
  28. Guidry C, 2009, INVEST OPHTH VIS SCI, V50, P1929, DOI 10.1167/iovs.08-2475
  29. Haddad A, 1998, EXP EYE RES, V66, P709, DOI 10.1006/exer.1997.0476
  30. Hammer DX, 2020, P NATL ACAD SCI USA, V117, P30661, DOI 10.1073/pnas.2010943117
  31. Iannetti L, 2011, INVEST OPHTH VIS SCI, V52, P5786, DOI 10.1167/iovs.10-7116
  32. Joshi M, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/192582
  33. KAMPIK A, 1981, ARCH OPHTHALMOL-CHIC, V99, P1445, DOI 10.1001/archopht.1981.03930020319025
  34. Kampik Anselm, 2012, Retina, V32 Suppl 2, pS194, DOI 10.1097/IAE.0b013e31825bc20a
  35. Kanda A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36917-9
  36. Kase S, 2006, BRIT J OPHTHALMOL, V90, P96, DOI 10.1136/bjo.2005.078394
  37. Kita T, 2008, P NATL ACAD SCI USA, V105, P17504, DOI 10.1073/pnas.0804054105
  38. Kita T, 2007, DIABETES, V56, P231, DOI 10.2337/db06-0581
  39. Kohno RI, 2009, BRIT J OPHTHALMOL, V93, P1020, DOI 10.1136/bjo.2008.155069
  40. Kritzenberger M, 2011, HISTOPATHOLOGY, V58, P953, DOI 10.1111/j.1365-2559.2011.03820.x
  41. Lakkaraju A, 2020, PROG RETIN EYE RES, V78, DOI 10.1016/j.preteyeres.2020.100846
  42. LAZARUS HS, 1994, ARCH OPHTHALMOL-CHIC, V112, P1356, DOI 10.1001/archopht.1994.01090220106031
  43. Li H, 2014, BIOCHEM BIOPH RES CO, V446, P347, DOI 10.1016/j.bbrc.2014.02.119
  44. Mascharak S, 2020, TRENDS MOL MED, V26, P1101, DOI 10.1016/j.molmed.2020.07.008
  45. Meuer SM, 2015, OPHTHALMOLOGY, V122, P787, DOI 10.1016/j.ophtha.2014.10.014
  46. Minchiotti S, 2008, RETINA-J RET VIT DIS, V28, P628, DOI 10.1097/IAE.0b013e31815ec275
  47. Nuzzi R, 2020, MOL VIS, V26, P818
  48. O'Koren EG, 2019, IMMUNITY, V50, P723, DOI 10.1016/j.immuni.2019.02.007
  49. Oberstein SYL, 2011, MOL VIS, V17, P1794
  50. Ohman T, 2018, AGING CELL, V17, DOI 10.1111/acel.12809
  51. Pakshir P, 2020, J CELL SCI, V133, DOI 10.1242/jcs.227900
  52. Parapuram SK, 2009, INVEST OPHTH VIS SCI, V50, P5965, DOI 10.1167/iovs.09-3621
  53. Ponsioen TL, 2008, MOL VIS, V14, P652
  54. Prinz M, 2017, NAT IMMUNOL, V18, P385, DOI 10.1038/ni.3703
  55. Qiao H, 2005, BRIT J OPHTHALMOL, V89, P513, DOI 10.1136/bjo.2004.050658
  56. Rathnasamy G, 2019, PROG NEUROBIOL, V173, P18, DOI 10.1016/j.pneurobio.2018.05.006
  57. Reichenbach A, 2020, GLIA, V68, P768, DOI 10.1002/glia.23727
  58. Reyes NJ, 2017, NAT REV IMMUNOL, V17, P322, DOI 10.1038/nri.2017.13
  59. Russo A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174297
  60. Saika S, 2004, LAB INVEST, V84, P1245, DOI 10.1038/labinvest.3700156
  61. Saika S, 2007, ARCH OPHTHALMOL-CHIC, V125, P647, DOI 10.1001/archopht.125.5.647
  62. Sakamoto T, 2011, RETINA-J RET VIT DIS, V31, P222, DOI 10.1097/IAE.0b013e3181facfa9
  63. Schumann RG, 2014, GRAEF ARCH CLIN EXP, V252, P1887, DOI 10.1007/s00417-014-2841-x
  64. Sebag J, 2004, GRAEF ARCH CLIN EXP, V242, P690, DOI 10.1007/s00417-004-0980-1
  65. Sebag J., 2014, VITREOUS, DOI [10.1007/978-1-4939-1086-1_10, DOI 10.1007/978-1-4939-1086-1_10]
  66. Shu DY, 2017, PROG RETIN EYE RES, V60, P44, DOI 10.1016/j.preteyeres.2017.08.001
  67. Simon MV, 2015, INVEST OPHTH VIS SCI, V56, P5808, DOI 10.1167/iovs.14-16195
  68. SMIDDY WE, 1989, OPHTHALMOLOGY, V96, P811
  69. Sommer F, 2008, GRAEF ARCH CLIN EXP, V246, P1275, DOI 10.1007/s00417-008-0846-z
  70. Tamiya S, 2016, EXP EYE RES, V142, P26, DOI 10.1016/j.exer.2015.02.008
  71. Usui-Ouchi A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158043
  72. Vecino E, 2016, PROG RETIN EYE RES, V51, P1, DOI 10.1016/j.preteyeres.2015.06.003
  73. Vera MS, 2021, EXP EYE RES, V202, DOI 10.1016/j.exer.2020.108359
  74. VINORES SA, 1990, INVEST OPHTH VIS SCI, V31, P14
  75. Vogt D, 2018, GRAEF ARCH CLIN EXP, V256, P1589, DOI 10.1007/s00417-018-4033-6
  76. Wang FE, 2010, FASEB J, V24, P1552, DOI 10.1096/fj.08-125856
  77. Wu D, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.14.29
  78. Xiao W, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014644
  79. Yu C, 2020, TRENDS NEUROSCI, V43, P433, DOI 10.1016/j.tins.2020.03.012
  80. Yu J, 2014, MOL BIOSYST, V10, P2558, DOI 10.1039/c4mb00240g
  81. Zhang W, 2020, J CELL MOL MED, V24, P12390, DOI 10.1111/jcmm.15739
  82. Zhao F, 2013, RETINA-J RET VIT DIS, V33, P77, DOI 10.1097/IAE.0b013e3182602087
  83. Zhou M, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00501
  84. Zhu MD, 2000, EXP EYE RES, V70, P767, DOI 10.1006/exer.2000.0844
  85. Zuchero JB, 2015, DEVELOPMENT, V142, P3805, DOI 10.1242/dev.129304

Coleções
Artigos e Materiais de Revistas Científicas - HC/Outros